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Abstract The growing awareness of the importance of
chirality in conjunction with biological activity has led to
an increasing demand for efficient methods for the
industrial synthesis of enantiomerically pure compounds.
Polyhydroxyalkanotes (PHAs) are a family of polyesters
consisting of over 140 chiral R-hydroxycarboxylic acids
(R-HAs), representing a promising source for obtaining
chiral chemicals from renewable carbon sources. Although
some R-HAs have been produced for some time and certain
knowledge of the production processes has been gained,
large-scale production has not yet been possible. In this
article, through analysis of the current advances in
production of these acids, we present guidelines for future
developments in biotechnological processes for R-HA
production.
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Introduction
The production of enantiomerically pure chemicals has long
been considered important in various sectors of the industry
including food supplements, pharmaceuticals, cosmetics,
fragrances, flavors, and other fine chemicals. In the case of
drugs, the presence of an undesirable enantiomer leads to
an increase in the dose required, and often also to adverse
side effects, such as thalidomide (Roth 2005). Many drugs
are now synthesized using chiral synthons provided either
by kinetic resolution of racemates, asymmetric synthesis or
via the naturally occurring chiral pool (Sheldon 1996). The
replacement of conventional–chemical processes by sus-
tainable biotechnological processes is one of the main
current tendencies in white biotechnology and biocatalysis
(Gavrilescu and Chisti 2005).
(R)-hydroxycarboxylic acids (R-HAs) can be widely used
as chiral precursors for several reasons: (i) they contain at
least two functional groups: a hydroxy group and a carboxy
group; (ii) the functional groups can easily be modified
chemically; and (iii) a second chiral center can be introduced.
The reported compounds using R-HAs as chiral building
blocks comprise the macrocyclic component of the antibiotic
elaiophylin (Sutter and Seebach 1983), the hydroxyacyl
hydrazines in visconsin, a peptide antibiotic (Hiramoto et al.
1971), pharmaceuticals such as captopril and β-lactams
(Ohashi and Hasegawa 1992a, b), and fungicides such as
norpyrenophorin and vermiculin (Seuring and Seebach 1978).
It has been reported that R-HAs can be obtained by
hydrolysis of biotechnologically synthesized polyhydroxyal-
kanoates (PHAs) (see review (Chen and Wu 2005a)). PHAs
are microbial polyesters, which are accumulated as a carbon
and energy storage material under particular environmental
conditions such as under nitrogen limitation (Lee 2000; Lenz
and Marchessault 2005). PHAs can be produced from
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renewable resources and are biodegradable and biocompat-
ible (Lee 2000; Lenz and Marchessault 2005). It is not
within the scope of this article to give a detailed review of
PHA biosynthesis and its applications (please see (Chen
2009), an excellent review on PHA). However, it is worth
mentioning that despite considerable work on production of
PHAs, only few commercial plants have been established in
the past few decades (Chen 2009). The drawbacks in
commercialization of PHA production could be attributed
to the high cost of production, limited microbial strains,
difficulty in recovering the polymer, and the presence of
impurities during industrial processing. This review mainly
focuses on the production of PHA-relevant R-HAs; other
types of R-HAs such as lactic acid are not included.
This article briefly reviews possible options for produc-
tion of R-HAs and their potential applications as illustrated
in Fig. 1. Furthermore, perspectives of the biotechnological
processes for R-HA production are also discussed.
Methods for R-HA production
Organic acids constitute a key group among the building-
block chemicals that can be produced by microbial processes
(Sauer et al. 2008). Most of them are natural products of
microorganisms, or at least natural intermediates in major
metabolic pathways. Because of their functional groups,
organic acids are extremely useful as starting materials for
the chemical industry. Although chiral hydroxycarboxylic
acids (HAs) are attractive compounds with much potential,
only few of these compounds are commercially available,
such as (R)-3-hydroxybutyric acid (R-3HB). So far, only two
enantiomerically pure R-HAs with more than 4 carbon atoms
are available on the market: (R)-3-hydroxynonanoic acid
(supplied by Exclusive Chemistry Ltd, Russia) and (R)-3-
hydroxytetradecanoic acid (supplied by Wako Pure Chemi-
cal Industries Ltd, Japan). A survey of the most interesting
(R)-3-hydroxycarboxylic acids is given in the Electronic
supplementary material. Although the market for R-HAs is
currently small, mainly due to high price and limited
availability, it can be envisioned that once an economical
viable microbial production process for one of these acids is
established, the market for it will undoubtedly increase.
Chemical synthesis of R-HAs
De novo synthesis
The introduction of the chiral center is the challenging step
when producing enantiomerically pure R-HAs. Different
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Fig. 1 Synthesis of R-HAs and their applications
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approaches have been reported. Classical organic synthesis
may include stereoselective oxidation through Sharpless’
asymmetric epoxidation and consecutive hydroxylation or
through Brown’s asymmetric allylboration (Brown and
Ramachandran 1991). Enantiopure 3-hydroxyesters have
been prepared chemically via enantioselective reduction using
3-keto esters as prochiral precursors (Noyori et al. 2004).
Recently, Spengler and Albericio (2008) reviewed various
possible routes for asymmetric synthesis of enantiopure or
enantiomerically enriched α-unsubstituted β-hydroxy acids
(3-hydroxycarboxylic acids). General drawbacks of these
reactions are the requirement of often expensive, chiral
metal-complex catalysts, the contamination of end product
with catalysts, and/or the high price of pure substrates.
Vigorous reaction conditions such as high pressure,
flammable reaction media, or cryogenic conditions are
often needed (Brown and Ramachandran 1991; Ikunaka
2003), and the range of possible products is limited.
Furthermore, the necessity to synthesize precursor molecules
may complicate the synthetic procedure and may reduce the
product yield (Nakahata et al. 1982; Wang et al. 1999).
Another main disadvantage can be lower enantiomeric
excesses (ee) compared to biochemical processes (Sheldon
1996).
Chemical degradation of PHA
PHAs comprise of monomers with 3-hydroxy, 4-hydroxy,
and 5-hydroxy groups. Up to date, about 140 R-HA
monomers have been identified (Steinbüchel and Valentin
1995; Sudesh et al. 2000). The length of the side chains
varies between 1 and 13 carbon atoms, and a broad range of
functional groups can be present, e. g. halogens, phenoxy,
acetoxy, phenyl, cyano, and epoxy groups (Steinbüchel and
Valentin 1995; Sudesh et al. 2000). All of the monomers
are enantiomerically pure and in (R)-configuration if they
possess a chiral center. Therefore, it was reasoned that
various enantiomerically pure R-HAs might be convenient-
ly prepared by depolymerizing biosynthesized PHAs. For
example, poly[(R)-3-hydroxybutyrate] (PHB) was for the
first time suggested to be a source for the chiral pool about
11 years ago (Lee et al. 1999).
Various enantiomerically pure R-HAs can be conveniently
prepared by depolymerizing the biosynthesized PHA. A
method for producing R-3HB and (R)-3-hydroxyvaleric acid
(R-3HV) from PHB and poly[(R)-3-hydroxybutyrate-co-(R)-
3-hydroxyvalerate] (PHBV) by chemical degradation has
been reported (Seebach et al. 1993). Lee et al. reported an
efficient method for the preparation of R-3HB by acidic
alcoholysis of PHB (Lee et al. 2000). de Roo et al. (2002)
produced the chiral medium chain length (mcl) (R)-3-
hydroxycarboxylic acids via hydrolytic degradation of PHAs
synthesized by Pseudomonas putida. PHAs were first
degraded by acid methanolysis, and then the obtained R-
HA methyl esters were distilled into several fractions.
Subsequently, the methyl esters were saponified to yield
the corresponding (R)-3-hydroxycarboxylic acids (de Roo et
al. 2002).
Biotransformation
Biotransformations are enzyme-catalyzed environmentally
friendly, regio- and stereoselective processes (Bommarius
and Riebel 2004). With regard to the production of R-HAs,
microorganisms have been used as biocatalysts to introduce
the chiral centers.
De novo biosynthesis
3-Hydroxyvaleric acid has been prepared by the hydroxyl-
ation of valeric acid in fermentation using Candida rugosa
(Hasegawa et al. 1981), and a single enantiomer of 3HV (R-
3HV) was similarly prepared using P. putida, Pseudomonas
fluorescens, Arthrobacter oxydans, or Arthrobacter crystal-
lopietes (Goodhue and Schaeffe 1971). 3-Hydroxypropionic
acid has been produced by fermentative conversion of
carbohydrates (Gokarn et al. 2001). The immobilized nitrile
hydratase and amidase from Rhodococcus sp. were used to
hydrolyze 3-hydroxypropionitrile, 3-hydroxyheptanenitrile,
and 3-hydroxynonanenitrile to the corresponding 3-
hydroxycarboxylic acids at yields of 63, 62, and 83%,
respectively (Deraadt et al. 1992); More recently, Hann et al.
(2003) used a combination of nitrile hydratase and amidase
activities of Comamonas testosteroni 5MGAM4D for the
hydrolysis of 3-hydroxyalkanenitriles to 3HAs. It was found
that the immobilized C. testosteroni 5MGAM4D in consec-
utive batch reactions was physically robust over 100 recycle
reactions, and the enzyme activities of the immobilized cells
were also very stable even after 106 days. This process is
being used for the production of 100-kg quantities of 3-
hydroxyvaleric acid (Hann et al. 2003). However, the
chirality of the obtained HAs using nitrile hydratase and
amidase was not investigated. If these HAs are racemic
mixtures, separation of R and S enantiomers will be needed
for their application as synthons.
Several (R)- and (S)-3-hydroxyalkanoic acids have been
prepared by the enzymatic reduction of the corresponding 3-
ketoalkanoic acids (Lemieux and Giguere 1951; Utaka et al.
1990). Utaka et al. (1990) reported the production of
optically active 3-hydroxy acids by asymmetric reduction
of aliphatic short- to long-chain β-keto acids by fermenting
baker’s yeast (Sih et al. 1984). 11 β-keto acids, ranging from
3-oxobutanoic to 3-oxooctanoic acids, were reduced to the
corresponding optically pure β-hydroxy acids, which were
isolated as methyl esters. In all cases, the R-hydroxy acids
were obtained in ≥98% ee, except for 3-oxobutanoic acid,
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which was converted to the S-hydroxy acid with 86% ee.
Inhibition of microbial fermentation was observed for
medium chain length oxo acids ranging from 3-
oxoundecanoic to 3-oxotetradecanoic acids, leading to no
reduction of these oxo acids (Sih et al. 1984; Utaka et al.
1990). C6–C12 (S)-3-hydroxyalkanoic acids have been
prepared from the corresponding trans-α,β unsaturated
alkanoic acids by microbial hydration catalyzed by resting
cells Mucor sp. (Tahara and Mitzutani 1978). (R)-3-
Hydroxyhexanoic acids (R-3HHx) and (R)-3-hydroxyhepta-
noic acid (R-3HP) have been prepared with a mutant strain
of C. rugosa (Hasegawa et al. 1983; Ohashi and Hasegawa
1992b).
Enzymatic degradation of purified PHA in vitro
Up to now, many extracellular PHA depolymerases
(ePhaZs) have been identified and characterized (see
reviews (Jendrossek and Handrick 2002; Kim et al.
2007)). The ePhaZs partially degrade crystallized or
denatured PHA, and the degradation products are typically
R-HA monomers and/or dimmers (Jaeger et al. 1995;
Jendrossek and Handrick 2002). ePhaZs have been mainly
used for surface modification (Numata et al. 2008), while
very few studies have been dedicated to R-HA production
using ePhaZs. It has been reported that thermophilic
Streptomyces sp. MG can hydrolyze purified PHB to R-
3HB (Calabia and Tokiwa 2006). An added advantage with
this strain is its stability at high temperature (50 °C), which
would minimize contamination problems. Furthermore,
downstream processing is relatively easy since the cells
aggregate to form clumps after the fermentation process.
Extracellular lipases from different bacteria were tested
for their ability to hydrolyze different types of polyesters to
produce HAs (Jaeger et al. 1995). It was found that most
lipases were able to hydrolyze polyesters consisting of an
omega-hydroxyalkanoic acid such as poly(6-hydroxyhex-
anoate) or poly(4-hydroxybutyrate). The dimeric ester of
hydroxyhexanoate was the main product of enzymatic
hydrolysis of polycaprolactone by P. aeruginosa lipase.
Polyesters containing side chains in the polymer backbone
such as PHB and other poly(3-hydroxyalkanoates) were not
or were only slightly hydrolyzed by the lipases tested
(Jaeger et al. 1995).
Enzymatic degradation of PHA in vivo in wild-type bacteria
Another attractive approach to obtain R-HAs from PHAs is
the in vivo depolymerization. The process utilizes intracel-
lularly located PHA depolymerases for hydrolysis of PHAs
(Foster et al. 1996; Foster et al. 1999; Jendrossek and
Handrick 2002). It has been efficiently accomplished with
natural PHB-synthesizing bacteria to produce R-3HB with
a yield of 96% (g R-3HB/g PHB) (Lee et al. 1999).
Appropriate environmental conditions are crucial for this
process. Lee et al. (1999) reported that, with Alcaligenes
latus (reclassified as Azohydrogenomonas lata (Xie and
Yokota 2005)), lowering the environmental pH to 3–4
resulted in the highest activity of intracellular PHB
depolymerase and blocked the reutilization of R-3HB by
the cells.
In order to gain access to more interesting molecules, in
vivo depolymerization of mcl-PHA in P. putida has been
studied (Ren et al. 2005; Ren Zulian et al. 2008; Ruth et al.
2007). PHA containing P. putida cells were suspended in
phosphate buffer at different pH values. At more alkaline pH
values (pH 9–11), the degradation of PHA and thus, the
release of R-HA monomers were at their best (Ren et al.
2005; Wang et al. 2007). Under such conditions, PHAs
containing R-3-hydroxyoctanoic acid (R-3HO) and R-3HHx
were degraded with an efficiency of over 90% (w/w) in 9 h,
and the yields of the corresponding monomers were also
over 90% (w/w). Under the same conditions, unsaturated
monomers R-3-hydroxy-6-heptenoic acid, R-3-hydroxy-8-
nonenoic acid, and 3-hydroxy-10-undecenoic acid were also
produced, although with a lower yield compared with the
saturated monomers (Ren et al. 2005).
It seems that PHB depolymerase of A. latus and mcl-PHA
depolymerase of P. putida need different pH values to have
the optimal activities to degrade PHA in vivo: the former at
acidic conditions (pH 3–4) and the latter at alkaline
conditions (pH 9–11) (Lee et al. 1999; Ren et al. 2005). In
vitro, all of the so-far characterized PHB depolymerases and
mcl-PHA depolymerase of P. putida exhibit optimal activ-
ities at the alkaline range (de Eugenio et al. 2007; Jendrossek
and Handrick 2002). The requirement for different pH values
could be caused by the difference between the intrinsic
properties of the PHB depolymerase of A. latus from those
of so-far analyzed depolymerases. However, this assumption
needs to be verified by further investigation.
R-HA production by metabolic pathway engineering
Metabolic engineering is a powerful tool to solve defined
biotechnological problems, such as enhancing intermediate
concentrations or broadening the range of precursors. Voll-
brecht et al. have reported to use a double mutant of Ralstonia
eutropha (Hydrogenomonas eutropha, Alcaligenes eutropha,
Wautersia eutropha, Cupriavidus necator), which is unable
to synthesize PHB and to utilize 3-hydroxybutanoate as a
substrate, to produce R-3HB (Vollbrecht et al. 1978;
Vollbrecht and Schlegel 1978, 1979). About 3.4 g/L of R-
3HB was produced under optimum conditions (Vollbrecht
and Schlegel 1979). There have been several reports on
metabolic engineering of Escherichia coli for the production
of R-3HB (Lee and Lee 2003; Park et al. 2004). When
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recombinant E. coli carrying the R. eutropha PHB synthetic
genes (β-ketothiolase (phaA), acetoacetyl-CoA reductase
(phaB) and PHB synthetase (phaC)), and the depolymerase
gene (phaZ) was cultivated in medium-containing glucose,
R-3HB was produced (Lee and Lee 2003). By integration of
the PHB biosynthetic genes into the chromosome of E. coli
together with providing a plasmid containing phaZ, R-3HB
could be efficiently produced without plasmid instability in
the absence of antibiotics (Lee and Lee 2003).
It was also reported that R-HAs can be produced by
recombinant organisms directly, without going through the
PHA hydrolysis process (Chen and Wu 2005b; Gao et al.
2002; Zhao et al. 2003). For example, recombinant E. coli
HB101 harboring PHB precursor genes phaA and phaB of R.
eutropha was able to produce more than 1 g/L of 3HB
monomer extracellularly after 48 h of fermentation (Wu et al.
2003). Heterologous expression of (R)-3-hydroxydecanol-
ACP:CoA transacylase gene (phaG) of P. putida in E. coli
HB101 led to extracellular production of 3-hydroxydecanoic
acid (3HD) from fructose with a yield of 0.587 g/L.
Simultaneous expression of both phaG and tesB (encoding
thioesterase II of E. coli) in E. coli HB101 increased 3HD
production compared with the expression of phaG alone
under identical conditions (Zheng et al. 2004). Recently,
TesB was found to be able to facilitate 3HB production (Liu
et al. 2007). E. coli BW25113 harboring phaA, phaB, and
tesB genes produced approximately 4 g/L 3HB in shake
flask culture within 24 h with glucose as a carbon source
(Zheng et al. 2004). The produced HAs mentioned here were
not analyzed for their chiral configuration. However, due to
the enzymatic activities of PhaB and PhaG, the obtained
HAs are very likely to be R-HAs.
A biosynthetic pathway for the production of (S)-3-
hydroxybutyric acid (S-3HB) from glucose was established
in recombinant E. coli by introducing phaA from R.
eutropha, the (S)-3-hydroxybutyryl-CoA dehydrogenase
gene from R. eutropha, or Clostridium acetobutylicum
ATCC824, and the 3-hydroxyisobutyryl-CoA hydrolase gene
from Bacillus cereus ATCC14579 (Lee et al. 2008). The
recombinant E. coli could synthesize enantiomerically pure
S-3HB in a concentration up to 10.3 g/L; the S-3HB
productivity was 0.21 g/L/h. It was also reported that the
chirality of 3HB could be controlled by metabolic pathway
engineering of E. coli strains (Tseng et al. 2009).The
engineered strain achieved titers of enantiopure R-3HB and
S-3HB as high as 2.92 h/L and 2.08 g/L, respectively, in
shake flask cultures within 2 days (Tseng et al. 2009).
1,3-Propanediol dehydrogenase (DhaT) and aldehyde
dehydrogenase (AldD) from P. putida KT2442 are
capable of transforming 1,4-butanediol (1,4-BD) to 4-
hydroxybutyrate (4HB) (Zhang et al. 2009a). Thus,
Aeromonas hydrophila 4AK4, E. coli S17-1, or P. putida
KT2442 harboring dhaT and aldD were used to produce
4HB. Recombinant A. hydrophila 4AK4 containing
dhaT and aldD was able to produce over 10 g/L 4HB
from 20 g/L 1,4-BD after 52 h of cultivation in a 6-L
fermenter (Zhang et al. 2009a). Recently, an economical,
high-titer method for the production of 4-hydroxyvalerate
(4HV) and 3-hydroxyvalerate (3HV) from the inexpensive
and renewable carbon source levulinic acid was developed
(Martin and Prather 2009). These hydroxyvalerates were
produced by periodically feeding levulinate to P. putida
KT2440 expressing the tesB gene from E. coli.
Sandoval et al. (2005) reported that 3-hydroxy-n-phenyl-
alkanoic acids can be produced by a genetically engineered
strain of P. putida U. Overexpression of the gene encoding
the poly(3-hydroxy-n-phenylalkanoate) (PHPhA) depoly-
merase (phaZ) in P. putida U avoids the accumulation of
these polymers as storage granules. The genetically
engineered strain of P. putida U (ΔfadBA; phaZ on
plasmid) can efficiently convert different n-phenylalkanoic
acids into their corresponding 3-hydroxy-n-phenylalkanoic
acids derivatives, and it excretes these compounds into the
culture broth. However, the obtained 3-hydroxy-n-phenyl-
alkanoic acids are racemic mixtures (Sandoval et al. 2005).
Medium chain length R-3HHx and R-3HO were pro-
duced by overexpressing the PHA depolymerase gene
(phaZ) of P. putida KT2442, together with the putative
long-chain fatty acid transport gene (fadL) of P. putida
KT2442 and acyl-CoA synthetase gene (fadD) of E. coli
MG1655 in P. putida KT2442 (Yuan et al. 2008). In a 48-
h fed-batch fermentation process conducted in a 6-L
fermenter with 3-L sodium octanoate mineral medium,
5.8 g/L of extracellular R-3HHx and R-3HO was obtained
in the fermentation broth (Yuan et al. 2008). P. putida
KTOY01, a PHA synthesis operon knockout mutant, was
used for the direct production of medium chain length R-
HAs without going through PHA synthesis (Chung et al.
2009). R-3HHx, R-3HO, R-3HD, and (R)-3-hydroxydode-
canoate (R-3HDD) were produced by P. putida KTOY01
carrying tesB using dodecanoate as a sole carbon source.
Potential applications of R-HAs
Since R-HAs contain a chiral center and two easily modified
functional groups (–OH and –COOH), they are valuable
synthons, i.e., they may serve as starting materials for the
synthesis of fine chemicals such as antibiotics, vitamins,
flavors, fragrances, and pheromones (Chiba and Nakai 1985;
Ohashi and Hasegawa 1992a; Seebach et al. 2001).
Chiral synthons for organic synthesis
As R-HAs are not readily available on the market and their
classical synthesis is rather tedious, only few synthetic
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routes using such reactants as starting material have been
reported. The α,β-unsaturated δ-lactone (R)-massoialactone
has been known as a constituent of natural medicine for
many centuries and has been isolated from Cryptocarya
massoia, as well as from jasmine flowers (Kaiser and
Lamparsky 1976). Like many aliphatic δ-lactones it occurs
in several food flavors and essential oils, which are widely
used due to their specific odor impression and low-
threshold concentration. Touati et al. succeeded with
the synthesis of massoialactone using a ruthenium-
arylphosphine catalyst [RuBr2((R)-SYNPHOS)] to produce
the intermediate (R)-3-hydroxyoctanoate through asymmet-
ric hydrogenation (Touati et al. 2006). Chiral synthesis of
another δ-lactone, 3,5-dihydroxydecanoic acid, via (R)-3-
hydroxyoctanoate has also been reported (Satō 1987). Both
syntheses use rather expensive complex metal catalysis to
introduce the chiral center. Hence, easy accessibility of R-
HAs would simplify these two and many other syntheses of
saturated and unsaturated aliphatic β-lactones, which are
interesting bioactive natural products.
Gloeosporone, containing a 14-membered macrolide, is an
autoinhibitor of spore germination, and (R)-3-hydroxyocta-
noate methyl ester can be used as reactant in its synthesis
(Schreiber et al. 1988). In this multistage synthesis, the
method of choice for producing this compound is an
asymmetric reduction of β-keto esters to cope with
stereochemical problems. A Ru(II)-BINAP catalyst has been
developed for introducing the proper chiral conformation
(Noyori et al. 1987). Challenging metal-catalyzed reactions
can be avoided when starting with (R)-3-hydroxyoctanoate
from a bacterial source.
Certain divinyl ether fatty acids inhibit mycelial growth
and spore germination in certain fungi (Graner et al. 2003).
R-HAs can serve as chiral precursors for the synthesis of
those compounds, e.g., (R)-3-hydroxyheptanoate was
reported to be obtained by several crystallization steps
from carcinogenic carbon tetrachloride for this purpose
(Hamberg 2005).
Linear-condensed triquinane sesquiterpenes are constit-
uents of essential oils in plants and of great economical
interest. Starting materials such as bicyclo[3.2.0]hept-3-en-
6-ones (Marotta et al. 1994a) or tetrahydro-2H-cyclopenta
[b]furan-2-ones (Marotta et al. 1994c) can be synthesized
with (R)-3-hydroxyhept-6-enoate as reactant. (R)-3-hydrox-
yhept-6-enoate is also a precursor for eremophilan carbo-
lactones (Hayakawa et al. 1988), which are valuable
compounds for drug synthesis and also known in traditional
Chinese medicine. These compounds have been shown to
have positive effects on blood circulation and rheumatism
and some were found to exhibit antimicrobial activities
(Zhang et al. 2004).
In fact, there are many bioactive and pharmaceutically
interesting molecules known containing R-HAs as sub-
structures. Hence, the accessibility of these chiral acids as
building blocks might open new synthetic routes towards
such important compounds. Table 1 illustrates the versatil-
ity of possible applications using R-HAs. In Table 1, only
R-HAs directly involved in the subsequent reactions have
been considered. Taking all possible biotechnologically
producible R-HAs into account, the number of potential
synthetic pathways towards pharmaceutically interesting
compounds increases enormously.
Homopolymers and tailor-made block copolymers
A special application of chiral 3HA is the possibility to
create tailor-made polymers when using them as monomers
in a condensation reaction. As in most polyester syntheses,
the challenge is to reach high molecular weights. Various
methods can be applied to condense R-HAs, in order to
build up polyesters. Crucial features of those reactions are
the activation of the carboxylic group and the removal of
water to shift the equilibrium to the polyester product side.
R-HAs can be activated by dicyclohexylcarbodiimide
(DCC), p-toluenesulfonyl chloride (TosCl), or 2,4,6-triiso-
propylbenzenesulfonyl chloride (TPS) in anhydrous sol-
vents at 25 °C to start the polymerization reaction (Hattori
et al. 1978). Triethyl amine (NEt3) has already been
described to trigger polymerization of HA at 0 °C (Arslan
et al. 2004). Boiling HCl or concentrated H2SO4 can also
be used to catalyze the release of water (Becker et al. 2001).
For conversion via titanium(IV) isopropoxide, a temperature
of 140 °C and reduced pressure are necessary (Kobayashi
and Hori 1993). Seebach et al. obtained PHB from its
monomers by adding COCl2 and pyridine at −78 °C
(Lengweiler et al. 1996; Seebach and Fritz 1999). So far,
only racemic starting materials or R-3HB have been used for
the above described reactions.
Zhang et al. (2009a) recently reported that R-4HB
could be produced by recombinant bacteria harboring
dhaT and aldD from 1,4-butanediol. Fermentation broth
containing 4HB was further used for production of
homopolymer poly(4-hydroxybutyrate) [P(4HB)] and
copolymers poly(3-hydroxybutyrate-co-4-hydroxybuty-
rate) [P(3HB-4HB)] by recombinant E. coli S17-1 or R.
eutropha H16 (Zhang et al. 2009a).
Since (R)-3-hydroxycarboxylic acids from bacterial
sources have 100% (R)-configuration, they always result
in polyesters composed of isotactic macromolecules. The
process of in vivo depolymerization of PHA to obtain R-
HAs and their consecutive polymerization might seem
circuitous. However, it may open a new way to the
synthesis of a totally isotactic class of homo-polyesters
with special characteristics and unique properties, especial-
ly considering that PHAs synthesized in bacteria are always
co-polyesters, with the exception of PHB and poly(3-
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hydroxyphenylvalerate). It is also feasible to synthesize
block or graft copolymers using several types of different 3-
hydroxycarboxylic acids as monomeric building blocks.
Synthesis of β-amino acids
Park et al. (2001) have reported previously that optically
active ethyl β-aminobutyrate can be prepared from R-HA.
Ethyl R-3HB was treated with p-toluenesulfonyl chloride
and sodium azide, leading to the formation of the
corresponding azido ester, which was then converted to
the β-amino acid by indium-mediated reduction. The
overall reaction proceeded with inversion of configuration.
This methodology is also expected to be applicable to the
preparation of primary amines from the corresponding
alcohols (Park et al. 2001). Peptides containing β-amino
acids are generally more stable to enzymatic hydrolysis due
to the inability of proteases and peptidases to cleave the
amide bonds adjacent to the β-amino acid (Park et al. 2001;
Seebach et al. 2001). Since β-peptides are stable towards
peptidases, they can be used as scaffolds for peptide mimics
(Chen and Wu 2005b). Certain β-peptides have antibacte-
rial, antiproliferative, or hemolytic properties (Chen and
Wu 2005b).
Table 1 Potential applications for selected R-HAs as synthons
R-HAs Potential synthon for Reference
(R)-3-hydroxyundec-10-enoate Inhibitor of cholesterol synthesis, effects
3-hydroxy-3-methyl-glutaryl (HMG) CoA synthetase
Dirat et al. (1998)
Precursor of L-659,699 (inhibitor of cholesterol
biosynthesis)
Chiang et al. (1989)
(R)-3-hydroxy-undecanoate Depsipeptides (antibiotic/antifungal) Nihei et al. (2005); Wohlrab et al. (2007)
(−)-tetrahydrolipstatin (anti-obesity drug) Pons and Kocienski (1989); Sarabia and
Chammaa (2005)
Lipid A mimic (immunobiological) Martin et al. (2006)
Stevastelins B and B3 Sarabia and Chammaa (2005)
Sulfobacin A Gupta et al. (2004); Irako and Shioiri (1998);
Labeeuw et al. (2004)
Globomycin (antibiotic, signal peptidase II inhibitor) Kiho et al. (2003a); Kiho et al. (2003b, 2004)
Pseudomycin Rodriguez et al. (2001)
Topostins B567 and D654 Irako and Shioiri (1998)
(R)-3-hydroxy-nonanoate Globomycin analogs (antibiotic) Kiho et al. (2004)
(R)-2-benzylcyclohexanone (precursor of natural
products)
Katoh et al. (1994)
(R)-3-hydroxyoctanoate Simvastatin (antihypercholesterolemic, inhibitor
of HMG-CoA reductase
Lee and Lee (2004); Morgan and Burk (2005)
Viscosin Hiramoto (1971)
(R)-3-hydroxyhept-6-enoate Potent HMG CoA reductase inhibitor FR901512 Inoue and Nakada (2007)
Rosuvastatin calcium, a HMG CoA reductase inhibitors Zlicar (2007)
α,β-disubstituted β-lactones Wu and Sun (2005)
Sphingofungin D (antifungal) Mori and Otaka (1994); Vanmiddlesworth
et al. (1992)
Sphingofungin F (antifungal) Kobayashi et al. (1997)
Precursor of β-lactams for synthesis
of carbacephems (class of antibiotics)
Crocker and Miller (1995)
Ebelactone A and B (β-lactone enzyme inhibitor) Paterson and Hulme (1995)
Bicycloheptenones Marotta et al. (1994b)
Cyclosporine A derivatives (immunosuppressive) Aebi et al. (1990); Colucci et al. (1990); Lynch
et al. (1987); Rich et al. (1989); Schmidt
and Siegel (1987); Schreiber et al. (1988)
(S)-citronellol Hirama et al. (1985)
(R)-3-hydroxyheptanoate Anachelin (siderophore of Anabaena cylindrica) Ito et al. (2004)
Pravastatin (atherosclerosis/hypercholesteremia agent) Keri et al. (2007)
(R)-3-hydroxyhexanoate Analogs of laulimalide (paclitaxel like
antimicrotubule agent)
Faveau et al. (2006)
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Medical applications
It is known that R-3HB is ubiquitous in all kinds of cells
(Chen 2009). Thus, one of the biggest advantages for R-
3HB is that it is well-tolerated by humans, i.e., it is
biocompatible. Recently, R-3HB has been employed to
treat traumatic injuries such as hemorrhagic shock, exten-
sive burns, myocardial damage, and cerebral hypoxia,
anoxia, and ischemia (Massieu et al. 2003; Tieu et al.
2003; Zou et al. 2009). It was also shown that 3HB
oligomers provide energy and show good penetration and
rapid diffusion in peripheral tissue; hence, they could be an
energy substrate for injured patients (Tasaki et al. 1999).
R-3HB could also serve as energy substrate in increasing
cardiac efficiency and thus, prevents brain damage
(Kashiwaya et al. 2000). There is also evidence that R-
3HB can correct defects in mitochondrial energy generation
in the heart (Katayama et al. 1994).
Furthermore, R-3HB has been found to be able to reduce
the death rate of the human neuronal cell model culture for
Alzheimer’s and Parkinson’s diseases and to ameliorate the
appearance of corneal epithelial erosion through suppres-
sion of apoptosis (Kashiwaya et al. 2000); R-3HB methyl
ester was also found to dramatically improve the memory
of mice (Zou et al. 2009).
Recently, R-3HB was clearly demonstrated to have a
positive effect on the growth of osteoblasts in vitro and an
anti-osteoporosis effect in vivo (Zhao et al. 2007). It was
found that R-3HB increased serum alkaline phosphatase
activity and calcium deposition, decreased serum osteocal-
cin, prevented bone mineral density reduction resulting
from ovariectomization, leading to enhanced femur maxi-
mal load and bone deformation resistance, as well as
improved trabecular bone volume (Zhao et al. 2007).
Antimicrobial agents
Fatty acids have been known as antimicrobial agents for
more than 80 years. They function as surface-active anionic
detergents (Kodicek 1949). Once the fatty acid has been
adsorbed by cells, the inhibitory effect might be brought
about by concomitant changes in cell permeability (Nieman
1954). It has been reported that the length of the carbon
chain plays an important role in the antimicrobial activity
(Nieman 1954). Some R-HAs exhibit antimicrobial or
antiviral effects, while other R-HAs do not.
Sandoval et al. (2005) reported that (R)-3-hydroxy-n-
phenylalkanoic acid can effectively attack Listeria mono-
cytogenes, which is an ubiquitous microorganism, and able
to multiply at refrigeration temperatures and is resistant to
both high temperature and low pH. R-3HB has been shown
to exhibit some antimicrobial, insecticidal, and antiviral
activities (Chen and Wu 2005b; Shiraki et al. 2006).
Recently, Ruth et al. (2007) tested medium chain length
R-HAs for their antimicrobial activities. It was found that
R-3HO, (R)-3-hydroxy-8-nonenoic acid, and (R)-3-hy-
droxy-10-undecenoic acid exhibited much higher activities
against the growth of Listeria species and Staphylococcus
aureus than their racemic mixtures or their non-
hydroxylated free fatty acid counterparts (Ruth et al. 2007).
Biofuel
Recently, Zhang et al. (2009b) proposed R-HA methyl
esters (R-HAME) as a new type of biofuel. They found that
the combustion heat of blended fuels, namely R-HAME—
diesel or R-HAME—gasoline, were lower than that of pure
diesel or gasoline but were usable as fuels. It was roughly
estimated that the production costs of R-HAME-based
biofuels from waste resources including waste water and
activated sludge should be around US$ 1,200/ton (Zhang et
al. 2009b). It was claimed that R-HAME-based biofuel
production from waste water or from activated sludge
enjoys the advantages of waste water treatment accompa-
nied by energy generation.
Perspectives of biotechnological production of R-HAs
For biotechnological production of R-HAs on a large scale,
it is important to not only consider yield, product
concentration, and productivity, but also the cost of
substrates and downstream processing, which are crucial
constraints for a process to become economically viable.
Often a bioprocess optimized for production as established
in academia does not necessarily represent the most
favorable conditions when viewed from an economic
standpoint. High substrate costs can abolish the advantage
of high yield, or high purification cost can limit any cost
advantages of an inexpensive carbon source. Clearly, these
factors are interrelated.
At present, large research efforts have been dedicated to
the use of lignocellulosic biomass. This is highly abundant
and significantly cheaper than refined sugar, making it an
interesting substrate for microbial production processes in
general. PHAs have been reported to be produced from
such biomass (Li et al. 2007; Munoz and Riley 2008; Yu
and Chen 2008; Yu and Stahl 2008). However, one has to
consider that lignocellulose comprises different types of
substances that might interfere with the bioprocess and that
require an extensive downstream processing, which would
add to the final costs. Further investigations are needed to
clarify these issues.
An integral part of process optimization must be the
reduction of the purification costs, but these are highly
interconnected with biological and economic factors.
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Purification costs are higher with less-purified substrates
and by-products can also constitute an important problem.
To ensure that minimum effort is required for purification,
the preceding bioprocess should avoid accumulation of
impurities as much as possible from the beginning of the
process. Ruth et al. (2007) reported a biotechnological
process to produce R-HAs. Here, chromatography was used
to purify R-HAs. To be economically viable, further
improvement of this process must be brought at the step
of R-HA purification. Only under such a condition can this
biotechnological process become attractive for industrial
production of R-HAs.
To gain the most from the producing organism, the process
must be optimized taking into account biological, as well as
economic constraints. Viewing the bioprocess for R-HA
production objectively, it appears that biomass accumulation
somehow wastes the carbon source. Instead of being
converted into PHAs (and subsequently R-HAs), the substrate
is converted into biomass. A number of studies are therefore
related to the idea of uncoupling biomass accumulation from
PHA production (Sun et al. 2009).
Very often there are problems that simply cannot be
solved by the proper selection of the production organism
and bioprocess engineering. The organisms themselves
must be altered in a rational way to be able to cope with
the constraints of cost-effective production. For example,
lignocellulosic biomass is an attractive substrate for PHA/
R-HA production. However, few microorganisms can
metabolize pentose sugars derived from these raw materials
(Lopes et al. 2009; Tian et al. 2009). Therefore, metabolic
engineering of strains might enable the efficient utilization
of this biomass. On the other hand, although the modifica-
tion of defined pathways in an organism is usually
straightforward, one should realize that only a few of these
approaches have been successfully used in industrial
applications. One of the reasons is exposure of the micro-
organisms to a variety of stresses. Stress requires the cell to
dedicate more effort to maintaining its natural equilibrium.
This greater effort leads to several consequences, including
a change in metabolic activity, lower growth rate, lower
viability, and lower productivity (Sauer et al. 2008). Strain
robustness, which is the ability of the microorganism to
withstand the production environment, is therefore a key
factor determining whether a bioprocess will be successful
and industrially viable.
For a biotechnological process for R-HA production to
be competitive at large scale, the following aspects have to
be taken into account: substrate cost, product purification,
and strain fitness. These aspects are interrelated, e.g., the
choice of substrate cannot be made without considering
downstream processing or strain fitness, the choice of strain
influences downstream processing due to by-products and
also influences the choice for substrates. Only when these
aspects are properly addressed does the biotechnological
process has the potential to be economically viable for
industrial production of R-HAs. Once such processes are
established, the applications of these chiral compounds in
chemical and pharmaceutical industries will be possible.
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